sofosbuvir
Showing 26 - 50 of 71
Hepatitis C Virus Infection Trial in China (Seraprevir, Sofosbuvir)
Unknown status
- Hepatitis C Virus Infection
- Seraprevir
- Sofosbuvir
-
Beijing, Beijing, China
- +21 more
Jun 27, 2019
Liver Disease Trial in New York, Dallas (sofosbuvir/ledipasvir, sofosbuvir, Ribavirin)
Hepatitis C, Chronic Trial in Karachi (Sofosbuvir)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
-
Karachi, Sindh, PakistanOjha, Duhs
Sep 13, 2018
Hepatitis C, Cirrhosis Trial in Tehran (Sofosbuvir, Ledipasvir, Ribavirin)
Completed
- Hepatitis C
- Cirrhosis
- Sofosbuvir
- +2 more
-
Tehran, Iran, Islamic Republic ofShariati Hospital
Apr 27, 2018
HIV-1 Infection, Hepatitis Trial in United States (Sofosbuvir, Ribavirin, Ledipasvir/Sofosbuvir)
Completed
- HIV-1 Infection
- Hepatitis
- Sofosbuvir
- +2 more
-
San Diego, California
- +11 more
Mar 29, 2018
End-Stage Renal Disease, Hepatitis C Trial in Baltimore (Zepatier, Ribavirin, Sofosbuvir)
Completed
- End-Stage Renal Disease
- Hepatitis C
- Zepatier
- +2 more
-
Baltimore, MarylandJohns Hopkins Hospital
Aug 8, 2018
Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (Sofosbuvir, Daclatasvir)
Completed
- Chronic Hepatitis C Infection
- Sofosbuvir
- Daclatasvir
-
Beijing, Beijing, China
- +1 more
Mar 16, 2018
Hepatitis C, HIV Infection Trial in Yaoundé, Abidjan, Dakar (Sofosbuvir, Ribavirin, Ledipasvir)
Completed
- Hepatitis C
- HIV Infection
- Sofosbuvir
- +2 more
-
Yaoundé, Cameroon
- +3 more
Dec 12, 2017
Hepatitis C, Chronic, Hepatitis C Virus Infection, Response to Therapy of Trial in China (Sofosbuvir, Ribavirin)
Completed
- Hepatitis C, Chronic
- Hepatitis C Virus Infection, Response to Therapy of
- Sofosbuvir
- Ribavirin
-
Beijing, Beijing, China
- +16 more
Mar 5, 2018
Chronic Hepatitis C Infection Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, Sofosbuvir, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ombitasvir/paritaprevir/ritonavir and dasabuvir
- +2 more
- (no location specified)
Nov 22, 2017
Hepatitis C, Chronic Trial in Washington, D.C., Bethesda (Sofosbuvir, Ledipasvir, GS-9669)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
- +3 more
-
Washington, D.C., District of Columbia
- +2 more
May 12, 2017
Hepatitis C Trial in Santoña (sofosbuvir, ledipasvir)
Completed
- Hepatitis C
- sofosbuvir
- ledipasvir
-
Santoña, Cantabria, SpainPenitentiary "El Dueso". Cantabria. Spain
May 17, 2017
Hepatitis C Trial in Australia, France (Daclatasvir, Sofosbuvir, Ribavirin)
Completed
- Hepatitis C
- Daclatasvir
- +2 more
-
Darlinghurst, New South Wales, Australia
- +9 more
Dec 5, 2016
Chronic Hepatitis C, Genotype 4 Chronic Hepatitis C Trial in Spain (Simeprevir, Sofosbuvir)
Completed
- Chronic Hepatitis C
- Genotype 4 Chronic Hepatitis C
- Simeprevir
- Sofosbuvir
-
Badalona, Spain
- +6 more
Sep 28, 2016
Hepatitis C, Cirrhosis Trial in Tehran (Sofosbuvir, Daclatasvir, Ribavirin)
Completed
- Hepatitis C
- Cirrhosis
- Sofosbuvir
- +2 more
-
Tehran, Iran, Islamic Republic ofShariati Hospital
Oct 16, 2016
Chronic HCV Infection Trial in India (Sofosbuvir, RBV)
Completed
- Chronic HCV Infection
- Sofosbuvir
- RBV
-
Hyderabad, Andhra Pradesh, India
- +12 more
Sep 2, 2016
Hepatitis C Virus Infection Trial in United States (Sofosbuvir, RBV)
Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)
Completed
- Hepatitis C
- Hepatocellular Carcinoma
- Sofosbuvir
- Ribavirin
-
Los Angeles, California
- +14 more
Jun 16, 2016